HIF1A and pancreatic neoplasm: Of note, in vitro and in vivo studies have also shown that use of a novel selective HIF-1α inhibitor potentiates fractionated radiation-induced pancreatic cancer cell death, with or without combined treatment with 5-fluorouracil or gemcitabine.